Prediction of fetal D status from maternal plasma: Introduction of a new noninvasive fetal RHD genotyping service

Transfusion

Volumn 42, Issue 8, 2002, Pages 1079-1085

  Finning, K M ^a,b,c   Martin, P G ^a,b,c   Soothill, P W ^a,b,c   Avent, N D ^a,b,c  

^a NHS BLOOD AND TRANSPLANT   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c UNIVERSITY OF THE WEST OF ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; RHESUS D ANTIBODY;

ARTICLE; BLOOD; FEMALE; FETUS; FETUS BLOOD; FORECASTING; GENE DOSAGE; GENETICS; GENOTYPE; HUMAN; MALE; METABOLISM; MULTIPLE PREGNANCY; PREGNANCY; SENSITIVITY AND SPECIFICITY; SEXUAL DEVELOPMENT; TWINS;

DNA; FEMALE; FETAL BLOOD; FETUS; FORECASTING; GENE DOSAGE; GENOTYPE; HUMANS; MALE; PREGNANCY; PREGNANCY, MULTIPLE; RHO(D) IMMUNE GLOBULIN; SENSITIVITY AND SPECIFICITY; SEX CHARACTERISTICS; TWINS;

EID: 0036692036     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.2002.00165.x     Document Type: Article

References (24)

1. 1 Wilson RD. Amniocentesis and chorionic villus sampling. Curr Opin Obstet Gynecol 2000 ; 12: 81 ‐ 86. DOI: 10.1097/00001703-200004000-00005
2. 2 Tabor A, Bang J, Norgaard‐Pedersen B. Feto‐maternal haemorrhage associated with genetic amniocentesis: results of a randomized trial. Br J Obstet Gynaecol 1987 ; 94: 528 ‐ 34.
3. 3 Murray JC, Karp LE, Williamson RA, Cheng EY, Luthy DA. Rh isoimmunization related to amniocentesis. Am J Med Genet 1983 ; 16: 527 ‐ 34.
4. 4 Lo YM, Lo ES, Watson N, et al. Two‐way cell traffic between mother and fetus: biologic and clinical implications. Blood 1996 ; 88: 4390 ‐ 95.
5. 5 Bianchi DW, Williams JM, Sullivan LM, et al. PCR quantitation of fetal cells in maternal blood in normal and aneuploid pregnancies. Am J Hum Genet 1997 ; 61: 822 ‐ 29.
6. 6 Little MT, Langlois S, Douglas Wilson R, Lansdorp P. Frequency of fetal cells in sorted subpopulations of nucleated erythroid and CD34+ hematopoietic progenitor cells from maternal peripheral blood. Blood 1997 ; 89: 2347 ‐ 58.
7. 7 Sohda S, Arinami T, Hamada H, et al. The proportion of fetal nucleated red blood cells in maternal blood: estimation by FACS analysis. Prenat Diagnos 1997 ; 17: 743 ‐ 52.
8. 8 Lo YM, Tein MS, Lau TK, et al. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet 1998 ; 62: 768 ‐ 75.
9. 9 Faas BH, Beuling EA, Christiaens GC, Von Dem Borne AE, Van Der Schoot CE. Detection of fetal RHD ‐specific sequences in maternal plasma. Lancet 1998 ; 352: 1196.
10. 10 Avent ND, Finning KM, Martin PG, Soothill PW. Prenatal determination of fetal blood group status. Vox Sang 2000 ; 78 (Suppl): 155 ‐ 62.
11. 11 Zhong XY, Holzgreve W, Hahn S. Detection of fetal Rhesus D and sex using fetal DNA from maternal plasma by multiplex polymerase chain reaction. Br J Obstet Gynaecol 2000 ; 107: 766 ‐ 69.
12. 12 Nelson M, Eagle C, Langshaw M, et al. Genotyping fetal DNA by non‐invasive means: extraction from maternal plasma. Vox Sang 2001 ; 80: 112 ‐ 16.DOI: 10.1046/j.1423-0410.2001.00019.x
13. 13 Lo YM, Magnus Hjelm N, Fidler C, et al. Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma. N Engl J Med 1998 ; 339: 1734 ‐ 38.
14. 14 Singleton BK, Green CA, Avent ND, et al. The presence of an RHD pseudogene containing a 37 base pair duplication and a nonsense mutation in africans with the RhD‐negative blood group phenotype. Blood 2000 ; 95: 12 ‐ 18.
15. 15 Daniels GL, Faas BH, Green CA, et al. The VS and V blood group polymorphisms in Africans: a serologic and molecular analysis. Transfusion 1998 ; 38: 951 ‐ 58.
16. 16 Ulm B, Svolba G, Ulm MR, Bernaschek G, Panzer S. Male fetuses are particularly affected by maternal alloimmunization to D antigen. Transfusion 1999 ; 39: 169 ‐ 73.
17. 17 Rouillac C, Puillandre P, Colin Y, Le Van Kim C, Cartron JP. Fetal RHD typing using DNA from maternal plasma: a prediagnosis study on 182 cases (abstract). Vox Sang 2000 ; 78 (Suppl): 0026.
18. 18 Avent ND, Reid ME. The Rh blood group system: a review. Blood 2000 ; 95: 375 ‐ 87 ; erratum in Blood 2000;95:2197.
19. 19 Avent ND. Molecular biology of the Rh blood group system. J Pediat Hematol Oncol 2001 ; 23: 394 ‐ 402.
20. 20 Wagner FF, Frohmajer A, Flegel WA. RHD positive haplotypes in D negative Europeans. BMC Genetics 2001 ; 2: 10. DOI: 10.1186/1471-2156-2-10
21. 21 Lo YM, Noakes L, Bowell PJ, Fleming KA, Wainscoat JS. Detection of fetal RhD sequence from peripheral blood of sensitized RhD‐negative pregnant women. Br J Haem 1994 ; 87: 658 ‐ 60.
22. 22 Chiu RW, Poon LL, Lau TK, et al. Effects of blood‐ processing protocols on fetal and total DNA quantification in maternal plasma. Clin Chem 2001 ; 47: 1607 ‐ 13.
23. 23 Robson SC, Lee D, Urbaniak S. Anti‐D immunoglobin in RhD prophylaxis. Brit J Obstet Gynaecol 1998 ; 105: 129 ‐ 34.
24. 24 Crowther CA, Keirse MJ. Anti‐D administration in pregnancy for preventing rhesus alloimmunisation. Cochrane Database Syst Rev 2000 ; 2: CD000020.